Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Late effects in children and adolescents after treatment for cancer].

Ugeskrift for laeger·2026
Same author

Lipoprotein(a), interleukin-6 and cardiovascular risk in a primary prevention setting.

Atherosclerosis·2026
Same author

Pulmonary Function Deficit and Clinical Associations in Childhood Acute Lymphoblastic Leukaemia Survivors: A National Retrospective ALL-STAR Lungs Cohort Study.

Pediatric pulmonology·2026
Same author

Plasma proteomic signature of the human menstrual cycle.

Nature medicine·2026
Same author

Fibrotic disease co-occurrence and associated risk of subsequent organ failure: a nationwide matched cohort study.

Rheumatology (Oxford, England)·2026
Same author

Association between IL-6 and hs-CRP and Cardiovascular Risk in Clinically Relevant Subgroups.

European journal of preventive cardiology·2026

Related Experiment Video

Updated: Dec 10, 2025

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

656

Optimized tool for evaluation of platelet function measured by impedance aggregometry.

Anna Schultz-Lebahn1, Mette Tiedemann Skipper2, Anne-Mette Hvas1,2

  • 1Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.

Platelets
|September 1, 2020
PubMed
Summary

Impedance aggregometry results depend on platelet count. This study optimized a tool to interpret platelet aggregation across normal and reduced platelet counts, improving diagnostic accuracy for platelet function tests.

Keywords:
Impedance aggregometryplatelet aggregationplatelet countplatelet function teststhrombocytopenia

More Related Videos

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

12.3K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.4K

Related Experiment Videos

Last Updated: Dec 10, 2025

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

656
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

12.3K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.4K

Area of Science:

  • Hematology
  • Clinical Pathology
  • Biomedical Engineering

Background:

  • Platelet aggregation measured by impedance aggregometry is significantly influenced by platelet count.
  • Previous work established a tool for interpreting results at reduced platelet counts based on linear correlation.

Purpose of the Study:

  • To optimize the impedance aggregometry interpretation tool.
  • To expand the model to accurately assess platelet aggregation across a wider range of platelet counts, including normal levels.

Main Methods:

  • Combined data from 266 healthy individuals across three studies.
  • Measured impedance aggregometry using four agonists: collagen, ADP, TRAP-6, and ristocetin.
  • Investigated platelet counts ranging from 26-425x10^9/L, including in vitro reduction.

Main Results:

  • Confirmed a strong positive linear correlation between platelet counts and platelet aggregation (p<0.001).
  • Established 95% prediction intervals for healthy platelet aggregation relative to platelet count.
  • Validated the expanded model's utility across diverse platelet counts.

Conclusions:

  • The optimized model provides a reliable tool for evaluating platelet aggregation.
  • This tool enhances the interpretation of impedance aggregometry results in clinical settings with varying platelet counts.
  • Improved accuracy in assessing platelet function is crucial for diagnosing and managing bleeding disorders.